607
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Concurrent use of alcohol and sedatives in Finnish general population

, ORCID Icon, , , ORCID Icon &
Pages 704-707 | Received 05 Oct 2021, Accepted 26 May 2022, Published online: 06 Jun 2022

References

  • Bachhuber, M. A., Hennessy, S., Cunningham, C. O., & Starrels, J. L. (2016). Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. American Journal of Public Health. American Public Health Association Inc, 106(4), 686–688. https://doi.org/10.2105/AJPH.2016.303061
  • Calhoun, S. R., Wesson, D. R., Galloway, G. P., & Smith, D. E. (1996). Abuse of flunitrazepam (rohypnol) and other benzodiazepines in Austin and South Texas. Journal of Psychoactive Drugs, 28(2), 183–189. https://doi.org/10.1080/02791072.1996.10524390
  • Dåderman, A. M., & Lidberg, L. (1999). Flunitrazepam (Rohypnol) abuse in combination with alcohol causes premeditated, grievous violence in male juvenile offenders. Journal of the American Academy of Psychiatry and the Law, 27(1), 83–99. https://europepmc.org/article/med/10212029 (Accessed 23 September 2020).
  • Del Río, M. C., Prada, C., & Alvarez, F. J. (2002). Do Spanish patients drink alcohol while undergoing treatment with benzodiazepines? Alcohol, 26(1), 31–34. https://doi.org/10.1016/S0741-8329(01)00195-1
  • Härkänen, T., Kaikkonen, R., Virtala, E., & Koskinen, S. (2014). Inverse probability weighting and doubly robust methods in correcting the effects of non-response in the reimbursed medication and self-reported turnout estimates in the ATH survey. BMC Public Health. BioMed Central Ltd, 14(1), 1–10. https://doi.org/10.1186/1471-2458-14-1150
  • Haynes, J. C., Farrell, M., Singleton, N., Meltzer, H., Araya, R., Lewis, G., & Wiles, N. J. (2005). Alcohol consumption as a risk factor for anxiety and depression: Results from the longitudinal follow-up of the National Psychiatric Morbidity Survey. The British Journal of Psychiatry : the Journal of Mental Science, 187(DEC.), 544–551. https://doi.org/10.1192/BJP.187.6.544
  • Hochstim, J. R. (1967). A critical comparison of three strategies of collecting data from households. Journal of the American Statistical Association, 62(319), 976–989. https://doi.org/10.1080/01621459.1967.10500909
  • Hollister, L. E. (1990). Interactions between alcohol and benzodiazepines. In Recent developments in alcoholism : An official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism (pp. 233–239). Retrieved 2020, September 23, from https://europepmc.org/article/med/1970665
  • Ilomäki, J., Paljärvi, T., Korhonen, M. J., Enlund, H., Alderman, C. P., Kauhanen, J., & Bell, J. S. (2013). Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: A systematic review. The Annals of Pharmacotherapy, 47(2), 257–268. https://doi.org/10.1345/APH.1R449
  • Janhsen, K., Roser, P., & Hoffmann, K. (2015). Probleme der Dauertherapie mit Benzodiazepinen und verwandten Substanzen: Verschreibungspraxis, Epidemiologie und Entzugsbehandlung. Deutsches Arzteblatt International, 112(1–2), 1–7. https://doi.org/10.3238/arztebl.2015.0001
  • Kurko, T. A. T., Saastamoinen, L. K., Tähkäpää, S., Tuulio-Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M. S., & Hietala, J. (2015). Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies. European Psychiatry : the Journal of the Association of European Psychiatrists, 30(8), 1037–1047. https://doi.org/10.1016/J.EURPSY.2015.09.003
  • Kurko, T., Saastamoinen, L. K., Tuulio-Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M., & Hietala, J. (2018). Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiology and Drug Safety, 27(6), 674–682. https://doi.org/10.1002/pds.4551
  • Lader, M. H. (1999). Limitations on the use of benzodiazepines in anxiety and insomnia: Are they justified? European Neuropsychopharmacology, 9(SUPPL. 6), S399–S405. https://doi.org/10.1016/S0924-977X(99)00051-6
  • Martin, P. (2003). The epidemiology of anxiety disorders: A review. Dialogues in Clinical Neuroscience Les Laboratoires Servier, 5(3), 281–298. https://doi.org/10.31887/dcns.2003.5.3/pmartin
  • McGrath, J. J., Lim, C. C. W., Plana-Ripoll, O., Holtz, Y., Agerbo, E., Momen, N. C., Mortensen, P. B., Pedersen, C. B., Abdulmalik, J., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Bromet, E. J., Bruffaerts, R., Bunting, B., de Almeida, J. M. C., de Girolamo, G., De Vries, Y. A., Florescu, S., and de Jonge, P. (2020). Comorbidity within mental disorders: A comprehensive analysis based on 145 990 survey respondents from 27 countries. Epidemiology and Psychiatric Sciences, 29, E153. https://doi.org/10.1017/S2045796020000633
  • Nattala, P., Leung, K. S., Abdallah, A. B., Murthy, P., & Cottler, L. B. (2012). Motives and simultaneous sedative-alcohol use among past 12-month alcohol and nonmedical sedative users. The American Journal of Drug and Alcohol Abuse, 38(4), 359–364. https://doi.org/10.3109/00952990.2011.643987
  • Perera, K. M. H., Tulley, M., & Jenner, F. A. (1987). The use of benzodiazepines among drug addicts. British Journal of Addiction, 82(5), 511–515. https://doi.org/10.1111/j.1360-0443.1987.tb01508.x
  • Taipale, H., Särkilä, H., Tanskanen, A., Kurko, T., Taiminen, T., Tiihonen, J., Sund, R., Tuulio-Henriksson,A., Saastamoinen, L., & Hietala, J. (2020). Incidence of and characteristics associated with long-term benzodiazepine use in Finland. JAMA network open, 3(10), e2019029. https://doi.org/10.1001/jamanetworkopen.2020.19029
  • Veldhuizen, S., Wade, T. J., & Cairney, J. (2009). Alcohol consumption among Canadians taking benzodiazepines and related drugs. Pharmacoepidemiology and Drug Safety, 18(3), 203–210. https://doi.org/10.1002/pds.1702
  • Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019b). The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend, 200, 95–114. https://doi.org/10.1016/j.drugalcdep.2019.02.033
  • Votaw, V. R., Witkiewitz, K., Valeri, L., Bogunovic, O., & McHugh, R. K. (2019a). Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders. Addictive Behaviors, 88, 48–55. https://doi.org/10.1016/j.addbeh.2018.08.010